Feline esophagitis History of food allergy IL-5 Diagnosis requires more than 15 eosinophils per high power field
"eosinophilic esophagitis"[MeSH Terms] AND diagnosis
| Cytokine | Role |
|---|---|
| IL-5 | Major eosinophil growth factor, survival signal, and recruiter - drives eosinophilic infiltration of the esophagus |
| IL-13 | Induces esophageal epithelial barrier disruption and eotaxin-3 production |
| IL-33 / TSLP | Activates T-regulatory and Th2 cells, initiating the inflammatory cascade |
| Eotaxin-3 | Chemokine that directly recruits eosinophils to the esophagus |
"The eosinophil density required for the diagnosis of eosinophilic esophagitis is generally more than 15 eosinophils per high-power field on both proximal and distal esophageal biopsies." - Cummings Otolaryngology, Head & Neck Surgery
"The presence of at least 15 eosinophils per HPF is required for a diagnosis, and it is also a cut-off for histological remission (<15 eos/HPF)." - Yamada's Textbook of Gastroenterology, 7e

| Feature | EoE | GERD |
|---|---|---|
| Location | Proximal/mid esophagus | Distal esophagus |
| Eosinophils | ≥15/HPF, superficial clusters | Scattered, usually <10/HPF |
| PPI response | Refractory | Responsive |
| Atopic history | Common | Not typical |
| Rings/furrows | Present | Absent |
Protein losing enteropathy Cerebriform appearance Menetrier ds Case study
TGF-α overexpression
↓
Overstimulation of EGFR (Epidermal Growth Factor Receptor) on gastric epithelial cells
↓
Massive proliferation of foveolar (surface mucous) cells
↓
Hyperplastic, elongated, tortuous, cystic glands → Giant rugal folds
↓
Loss of parietal cells → Hypochlorhydria/Achlorhydria
Loss of protein across leaky mucosa → Hypoalbuminemia → Edema
A 55-year-old man presents with progressive peripheral edema, epigastric discomfort, and weight loss over several months. Labs show hypoalbuminemia with a normal 24-hour urine protein. Upper endoscopy reveals massively enlarged, lobular, cerebriform gastric folds in the fundus and body with antral sparing. Biopsy shows massive foveolar hyperplasia with elongated, corkscrew-shaped, cystic glands and markedly reduced parietal and chief cells. Gastric acid secretion is absent.Diagnosis: Ménétrier's Disease


| Feature | Ménétrier Disease | Zollinger-Ellison Syndrome |
|---|---|---|
| Location | Body + fundus | Fundus |
| Dominant cell | Mucous (foveolar) | Parietal > mucous |
| Gastric acid | Reduced/absent | Markedly increased |
| Protein loss | Yes | No |
| Associated pathology | TGF-α overexpression | Gastrinoma (MEN-1) |
| Dysplasia/cancer risk | Yes | No |
| Approach | Details |
|---|---|
| Supportive | IV albumin infusions, parenteral nutritional supplementation |
| Treat underlying infection | H. pylori eradication, antiviral therapy for CMV |
| Acid suppression | PPIs, H2 blockers (inconsistent benefit) |
| Anti-EGFR therapy | Cetuximab (monoclonal anti-EGFR antibody) - near-complete histologic remission in 4/7 patients in trials - the most targeted therapy |
| Other agents | Octreotide (somatostatin analogue), anticholinergics, corticosteroids |
| Surgery | Gastrectomy for severe, refractory cases; also performed when malignancy cannot be excluded |
In children: disease is usually self-limited; viral clearance (CMV) leads to normalization of epithelial proliferation and restoration of gastric anatomy without surgery.
Cerebriform nuclei with sezary cells
"Sézary syndrome is characterized by the triad of diffuse erythroderma, generalized lymphadenopathy, and circulating malignant T cells with cerebriform nuclei - so-called Sézary cells."
- Fitzpatrick's Dermatology
| Component | Details |
|---|---|
| 1. Erythroderma | Generalized, intense fiery-red skin involvement; severe pruritus, burning, episodes of chills |
| 2. Generalized lymphadenopathy | Cervical, axillary, inguinal nodes enlarged |
| 3. Circulating Sézary cells | Malignant T cells with cerebriform nuclei in peripheral blood |

Mycosis Fungoides (skin-limited CTCL)
Patch phase → Plaque phase → Tumor phase
↓
Sézary Syndrome (leukemic phase)
[erythroderma + blood involvement]
| Feature | Description |
|---|---|
| Epidermotropism | Neoplastic T cells infiltrate the epidermis (hallmark) |
| Pautrier microabscesses | Clusters of neoplastic T cells within the epidermis - pathognomonic |
| Cerebriform nuclei | Marked nuclear membrane infolding in infiltrating T cells |
| Band-like dermal infiltrate | Lymphocytes in upper dermis with admixed histiocytes, eosinophils |
| Minimal spongiosis | Unlike reactive eczema |
"T cells with irregular nuclei show single-cell infiltration of the epidermis and often form clusters known as Pautrier abscesses... The nuclei of at least a portion of neoplastic cells typically have a cerebriform appearance." - Henry's Clinical Diagnosis and Management by Laboratory Methods
| Marker | Sézary Cells |
|---|---|
| CD3 | + |
| CD4 | + (Th2 phenotype) |
| CD8 | - |
| CD7 | Lost (in ~2/3 of cases - key aberrant loss) |
| CD26 | Lost (majority of cases - useful diagnostic marker) |
| CD158k/KIR3DL2 | Aberrantly expressed (normally on NK cells only) |
Note: Sézary cells alone on cytomorphology are not sufficient - they can be found in other inflammatory erythrodermas (reactive conditions). Clonality must be proven.
| Disease | Median Survival |
|---|---|
| MF (patch/plaque stage) | ~10 years |
| Sézary Syndrome | ~3-5 years (5-year OS: 24-43%) |
| Modality | Notes |
|---|---|
| Low-dose methotrexate | ~50% response rate; median survival ~101 months |
| Extracorporeal photopheresis (ECP) | Photophoresis with combination agents; median survival 39-60 months |
| Total skin electron beam (TSEB) radiation | Complete cutaneous responses; also reduces blood burden |
| PUVA + retinoids + interferon-α | Combination skin-directed/systemic |
| Vorinostat / romidepsin | HDAC inhibitors |
| Mogamulizumab | Anti-CCR4 antibody; approved for relapsed/refractory MF/SS |
| Alemtuzumab | Anti-CD52 |
| Zanolimumab | Anti-CD4 |
Steatorrhoea with duodenal biopsy Fat cells Acanthocytes
Normal pathway:
Dietary fat → Enterocyte → MTP transfers lipids to ApoB48 → Chylomicron → Lymphatics → Blood
ABL:
MTP mutation → Cannot transfer lipids to ApoB48
→ Chylomicrons CANNOT be formed
→ Lipids TRAPPED inside enterocytes (vacuoles)
→ Fat-laden enterocytes on biopsy
→ Steatorrhoea
→ Fat-soluble vitamin deficiency (A, D, E, K)
| Isoform | Site | Lipoprotein formed | In ABL |
|---|---|---|---|
| ApoB48 | Enterocytes (edited mRNA) | Chylomicrons | ABSENT |
| ApoB100 | Hepatocytes (unedited mRNA) | VLDL, LDL | ABSENT |
"In the intestine, endoscopic examination reveals a white frosting appearance coating the duodenum and jejunum due to the lipid content in the mucosa. On histological examination, the enterocytes are filled with numerous lipid-filled cytoplasmic vacuoles." - Yamada's Textbook of Gastroenterology, 7e
"Failure to absorb essential fatty acids leads to deficiencies of fat-soluble vitamins as well as lipid membrane defects that can be recognized by the presence of acanthocytes (red cells with spiky membrane protrusions) in peripheral blood smears." - Robbins, Cotran & Kumar Pathologic Basis of Disease
| Age | Manifestations |
|---|---|
| Infancy | Failure to thrive, diarrhea, steatorrhoea, vomiting, abdominal distension |
| Childhood | Fat-soluble vitamin deficiencies become clinically apparent |
| 1st-2nd decade | Neurological + retinal complications if untreated |
| Late | Cardiac complications (cardiomyopathy) |
| Deficiency | Consequence |
|---|---|
| Vitamin E (most severely depleted - no alternative transport) | Spinocerebellar degeneration, peripheral neuropathy, retinitis pigmentosa |
| Vitamin A | Night blindness, retinal degeneration |
| Vitamin K | Coagulopathy (prolonged PT) |
| Vitamin D | Metabolic bone disease |
| Essential fatty acids | Acanthocytosis, membrane instability |
"Most untreated patients develop retinitis pigmentosa, peripheral neuropathy, and spinocerebellar degeneration during the first two decades of life." - Bradley and Daroff's Neurology in Clinical Practice
| Test | Result |
|---|---|
| Serum cholesterol | Markedly low (20-50 mg/dL; normal >150) |
| Triglycerides (fasting) | <10 mg/dL |
| Post-fat-load triglycerides | No rise (diagnostic) |
| Post-fat-load chylomicrons | Absent (diagnostic) |
| Plasma ApoB48, ApoB100 | Absent |
| Vitamin E | Extremely low |
| Vitamins A, D, K | Low (but less severely) |
| Peripheral smear | Acanthocytes |
| Feature | Finding |
|---|---|
| Genetics | Autosomal recessive; MTP gene mutation; consanguinity common |
| Endoscopy | White frosting of duodenum/jejunum |
| Duodenal biopsy | Lipid-vacuolated enterocytes (Oil Red O +); normal villous architecture |
| Blood smear | Acanthocytes (spur cells) |
| Lipid panel | Absent ApoB, absent chylomicrons, hypocholesterolaemia |
| Neuroimaging | Spinocerebellar atrophy in advanced cases |
| Intervention | Details |
|---|---|
| Dietary fat restriction | <15 g fat/day - minimizes steatorrhoea |
| Medium-chain triglycerides (MCT) | Absorbed directly without chylomicron packaging - provides calories |
| Vitamin E supplementation | 100 mg/kg/day (vs. normal 10-30 mg/day) - prevents/arrests neurological complications. If started early (before 16 months), neurological and retinal symptoms do not develop |
| Vitamins A, K, D | Standard supplementation; adequate levels achievable |
Key point: Early treatment with high-dose vitamin E can prevent neurological deterioration entirely. Late treatment can halt or partially reverse progression. - Yamada's Textbook of Gastroenterology, 7e
Carneys triad and carneys complex
| Component | Tumor |
|---|---|
| 1 | Gastric GIST (Gastrointestinal Stromal Tumor) - often multifocal, with lymph node involvement |
| 2 | Extra-adrenal Paraganglioma |
| 3 | Pulmonary Chondroma |
All three need not be present simultaneously - the triad may be incomplete and evolve over time.
| Feature | Detail |
|---|---|
| Inheritance | Sporadic - NOT familial, NOT inherited |
| Gender | Predominantly young females |
| Age | Young patients (often <30 years at presentation) |
| Genetics | Unknown cause - NOT associated with SDH gene mutations (unlike Carney-Stratakis) |
| GIST molecular profile | KIT/PDGFRA mutation-negative; SDHB-negative by IHC |
| Imatinib response | Generally ineffective (KIT/PDGFRA wild-type) |
"The Carney triad is a syndrome of unknown cause defined by the co-occurrence of GIST, paraganglioma, and pulmonary chondroma, usually occurring in females." - Robbins, Cotran & Kumar Pathologic Basis of Disease
| Carney Triad | Carney-Stratakis Dyad | |
|---|---|---|
| Components | GIST + Paraganglioma + Pulmonary chondroma | GIST + Paraganglioma (only 2) |
| Inheritance | Sporadic | Familial (autosomal dominant) |
| Genetics | SDH mutation absent | SDH gene mutations (SDHA/B/C/D germline) |
| SDHB IHC | Negative | Negative |
| Family history | Absent | Present - family members also affected |
"Evaluation has identified that tumors part of the Dyad carry mutations in the SDH family of genes, whereas those associated with the triad do not have such mutations." - Sleisenger & Fordtran's GI and Liver Disease
| Feature | Frequency |
|---|---|
| Cardiac myxomas | 79% - any of 4 chambers; recurrent in 20%; can embolize |
| Spotty skin pigmentation (lentigines, blue nevi - epithelioid type) | 65% |
| Primary Pigmented Nodular Adrenocortical Disease (PPNAD) → Cushing syndrome | 45% |
| Cutaneous myxomas (<1 cm papules; ears, eyelids, nipples) | 45% |
| Testicular tumors (large-cell calcifying Sertoli cell tumors → sexual precocity/gynecomastia) | 56% of males |
| Mammary myxoid fibromas | 30% |
| Pituitary somatotrope adenoma → Acromegaly | ~10% |
| Psammomatous melanotic schwannomas (sympathetic chain, upper GI) | Present |
| Thyroid tumors, ovarian cysts | Variable |
"Carney complex is an autosomal dominant disorder characterized by spotty skin pigmentation, myxomas (heart, skin, breast), psammomatous melanotic schwannomas, and endocrine tumors involving the adrenals, Sertoli cells, somatotropes, thyroid, and ovary." - Harrison's Principles of Internal Medicine, 22e
| Type | Gene | Chromosome |
|---|---|---|
| CNC Type 1 (majority, ~50%) | PRKAR1A (Protein Kinase A Regulatory Subunit 1α) - tumour suppressor | 17q22-24 |
| CNC Type 2 | Unknown gene | 2p16 |
| Feature | Carney TRIAD | Carney COMPLEX |
|---|---|---|
| Year described | 1970s | 1985 |
| Nature | Tumour syndrome | Neoplasia + pigmentation + endocrine syndrome |
| Inheritance | Sporadic | Autosomal dominant |
| Gene | Unknown (not SDH) | PRKAR1A (17q) |
| Key tumours | GIST + Paraganglioma + Pulmonary chondroma | Cardiac myxoma + Endocrine tumours + Schwannoma |
| Gender predominance | Young females | Either sex |
| Life-threatening lesion | Paraganglioma | Cardiac myxoma (embolism) |
| Skin findings | None specific | Lentigines, blue nevi (lips, conjunctiva) |
| Cushing syndrome | No | Yes (PPNAD) - atypical (thin patient) |
| SDH mutation | Absent | Not relevant |
| Family screening | Not needed | Mandatory (AD inheritance) |
| GIST molecular type | KIT/PDGFRA wild-type, SDHB-negative | Not a feature |
Hepatitis c infection with councilman bodies
| Term | Used in | Meaning |
|---|---|---|
| Councilman body | Yellow fever only | Apoptotic hepatocyte first described by William Thomas Councilman in yellow fever (1890) |
| Acidophil body | All other forms of hepatitis (including HCV) | The same morphological entity - apoptotic hepatocyte - but called "acidophil body" by convention in viral hepatitis, drug-induced liver injury, etc. |
"Apoptotic hepatocytes were first clearly described in yellow fever by William Thomas Councilman and therefore have been referred to as Councilman bodies; while apoptosis occurs in many forms of liver disease, by convention this eponym is restricted to that disease. In other settings in which apoptotic hepatocytes are seen (e.g., acute and chronic hepatitis), the term acidophil bodies is used, due to their deeply eosinophilic staining characteristics."
- Robbins, Cotran & Kumar Pathologic Basis of Disease
Hepatocyte under immune attack (CD8+ T cells, cytokines)
↓
Caspase activation → Programmed cell death
↓
Hepatocyte SHRINKS (opposite of necrosis which swells)
↓
Nuclear chromatin condensation (pyknosis)
↓
Nuclear fragmentation (karyorrhexis)
↓
Cell fragments into small, densely eosinophilic globules
↓
ACIDOPHIL BODY (deeply pink/eosinophilic, anucleate or with pyknotic nucleus)

| Feature | Description |
|---|---|
| Acidophil bodies | Scattered apoptotic hepatocytes - shrunken, deeply eosinophilic, anucleate; hallmark of ongoing hepatocyte death |
| Portal tract lymphoid aggregates | Dense lymphoid follicle-like aggregates in portal tracts - characteristic of HCV (less common in HBV) |
| Bile duct damage | Lymphocytic infiltration and damage of interlobular bile ducts ("biliary injury") - HCV-specific |
| Steatosis | Macrovesicular fat - particularly prominent in HCV genotype 3 (direct viral steatosis); also in other genotypes (metabolic steatosis) |
| Interface hepatitis | Lymphocytic spillover from portal tracts into surrounding periportal hepatocytes ("piecemeal necrosis") |
| Lobular inflammation | Scattered intralobular lymphocytes and Kupffer cell activation |
| Sinusoidal lymphocytosis | Single-file lymphocytes in sinusoids ("string of beads") |
| Perisinusoidal/pericellular fibrosis | With progressive disease |
| Cirrhosis | End-stage - nodular regeneration with bridging fibrosis |
HCV RNA replication in hepatocytes
↓
Viral antigens presented on MHC Class I
↓
CD8+ cytotoxic T lymphocytes recognize and attack infected hepatocytes
↓
Perforin/granzyme pathway → Caspase activation → APOPTOSIS
Fas/FasL pathway → Caspase activation → APOPTOSIS
↓
Acidophil bodies form
↓
Hepatic stellate cell activation by cytokines (TGF-β, TNF-α)
↓
Perisinusoidal myofibroblasts → Collagen deposition → FIBROSIS → CIRRHOSIS
"Adaptive immune cells play a critical role in viral hepatitis, with CD4+ and CD8+ T cells being particularly important in the eradication of virus-infected hepatocytes and in causing liver injury in chronic disease." - Robbins & Kumar Basic Pathology
| Point | Fact |
|---|---|
| Councilman bodies = Yellow fever only | First described by W.T. Councilman, 1890 |
| Same structure in HCV = Acidophil bodies | Named for deep eosinophilic staining |
| Mechanism | Hepatocyte apoptosis (NOT necrosis) |
| Morphology | Shrunken, deeply eosinophilic, pyknotic/anucleate globules |
| HCV-specific histological features | Portal lymphoid aggregates + bile duct damage + steatosis + acidophil bodies |
| Ground glass cells | HBV only (NOT HCV) |
| Fibrosis driver | Hepatic stellate cell → myofibroblast → collagen |